---
figid: PMC7696523__ijms-21-08596-g001
figtitle: Canonical Hedgehog signaling in Basal Cell Carcinoma
organisms:
- Homo sapiens
- Rattus norvegicus
- Paraechinus aethiopicus
organisms_ner:
- Homo sapiens
- Rattus norvegicus
- Drosophila melanogaster
- Danio rerio
pmcid: PMC7696523
filename: ijms-21-08596-g001.jpg
figlink: pmc/articles/PMC7696523/figure/ijms-21-08596-f001/
number: F1
caption: 'Schematic overview of canonical Hedgehog signaling in Basal Cell Carcinoma.
  Hh signaling pathway: quiescent: in the absence of an Hh ligand, PTCH inhibits SMO,
  thus, indirectly permitting SUFU to bind to, and thereby inactivate GLI transcription
  factors. Activated: binding of an Hh ligand to PTCH relieves PTCH-mediated inhibition
  of SMO, thereby inhibiting SUFU binding to GLI transcription factors, enabling the
  latter to enter the nucleus and activate Hh target genes. Inhibited: binding of
  a SMO inhibitor (vismodegib; sonidegib) relieves SMO-mediated inhibition of SUFU
  binding to GLI transcription factors, which are thereby inactivated. Abbreviations:
  PTCH, Patched receptor; Hh, Hedgehog; SMO, Smoothened; GLI, Glioma-associated oncogene
  homologue; SUFU, Suppressor of fused; EMT, Epithelial-mesenchymal transition.'
papertitle: 'A Vismodegib Experience in Elderly Patients with Basal Cell Carcinoma:
  Case Reports and Review of the Literature.'
reftext: Anna Passarelli, et al. Int J Mol Sci. 2020 Nov;21(22):8596.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8206009
figid_alias: PMC7696523__F1
figtype: Figure
redirect_from: /figures/PMC7696523__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7696523__ijms-21-08596-g001.html
  '@type': Dataset
  description: 'Schematic overview of canonical Hedgehog signaling in Basal Cell Carcinoma.
    Hh signaling pathway: quiescent: in the absence of an Hh ligand, PTCH inhibits
    SMO, thus, indirectly permitting SUFU to bind to, and thereby inactivate GLI transcription
    factors. Activated: binding of an Hh ligand to PTCH relieves PTCH-mediated inhibition
    of SMO, thereby inhibiting SUFU binding to GLI transcription factors, enabling
    the latter to enter the nucleus and activate Hh target genes. Inhibited: binding
    of a SMO inhibitor (vismodegib; sonidegib) relieves SMO-mediated inhibition of
    SUFU binding to GLI transcription factors, which are thereby inactivated. Abbreviations:
    PTCH, Patched receptor; Hh, Hedgehog; SMO, Smoothened; GLI, Glioma-associated
    oncogene homologue; SUFU, Suppressor of fused; EMT, Epithelial-mesenchymal transition.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - DHH
  - IHH
  - SHH
  - SMO
  - SMOX
  - PTCH2
  - GLI1
  - GLI2
  - SUFU
  - ITK
  - SLC22A3
  - Smo
  - Ptch2
  - Ptch1
  - Gli1
  - Gli2
  - Sufu
  - Slc22a3
  - smo
  - sm
  - Gli
  - ci
  - Su(fu)
  - 'Off'
  - 'On'
  - Fhos
  - ptch2
  - gli
  - gli2a
  - sufu
  - Sonidegib
  - CHLL
---
